122
Views
21
CrossRef citations to date
0
Altmetric
Original Article

An open clinical trial of naltrexone for amphetamine dependence: Compliance and tolerability

, , &
Pages 167-171 | Accepted 18 Jan 2005, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lam Lam, Shweta Anand, Xue Li, ML. Tse, Jia X. Zhao & Esther W. Chan. (2019) Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials. Clinical Toxicology 57:4, pages 225-233.
Read now
William W Stoops & Craig R Rush. (2014) Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research. Expert Review of Clinical Pharmacology 7:3, pages 363-374.
Read now

Articles from other publishers (19)

Jinny Claire Lee & Kim D. Janda. (2021) Immunopharmacotherapeutic advancements in addressing methamphetamine abuse. RSC Chemical Biology 2:1, pages 77-93.
Crossref
Nicole K. Lee, Linda Jenner, Angela Harney & Jacqui Cameron. (2018) Pharmacotherapy for amphetamine dependence: A systematic review. Drug and Alcohol Dependence 191, pages 309-337.
Crossref
Joar Guterstam, Nitya Jayaram-Lindström, Jonathan Berrebi, Predrag Petrovic, Martin Ingvar, Peter Fransson & Johan Franck. (2018) Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study. Drug and Alcohol Dependence 191, pages 91-97.
Crossref
Valgerdur Runarsdottir, Ingunn Hansdottir, Thorarinn Tyrfingsson, Magnus Einarsson, Karen Dugosh, Charlotte Royer-Malvestuto, Helen Pettinati, Jag Khalsa & George E. Woody. (2017) Extended-Release Injectable Naltrexone (XR-NTX) With Intensive Psychosocial Therapy for Amphetamine-Dependent Persons Seeking Treatment: A Placebo-Controlled Trial. Journal of Addiction Medicine 11:3, pages 197-204.
Crossref
Dan-Ni Cao, Jing-Jing Shi, Wei Hao, Ning Wu & Jin Li. (2016) Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction. European Journal of Pharmacology 780, pages 129-135.
Crossref
Hollis C. Karoly, Sophie L. YorkWilliams & Kent E. Hutchison. (2015) Clinical Neuroscience of Addiction: Similarities and Differences Between Alcohol and Other Drugs. Alcoholism: Clinical and Experimental Research 39:11, pages 2073-2084.
Crossref
Reshmi Pal, John E. Mendelson, Keith Flower, Kathleen Garrison, Garret Yount, Jeremy R. Coyle & Gantt P. Galloway. (2015) Impact of Prospectively Determined A118G Polymorphism on Treatment Response to Injectable Naltrexone Among Methamphetamine-Dependent Patients. Journal of Addiction Medicine 9:2, pages 130-135.
Crossref
George E. Woody. (2014) Antagonist Models for Treating Persons With Substance use Disorders. Current Psychiatry Reports 16:10.
Crossref
Shih-Ku Lin. (2014) Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature. British Journal of Clinical Pharmacology 77:2, pages 242-252.
Crossref
Colin N. Haile & Thomas R. Kosten. (2013) Pharmacotherapy for Stimulant-Related Disorders. Current Psychiatry Reports 15:11.
Crossref
Matthew Brensilver, Keith G. Heinzerling & Steven Shoptaw. (2013) Pharmacotherapy of amphetamine-type stimulant dependence: An update. Drug and Alcohol Review, pages n/a-n/a.
Crossref
Erin Kelty, Karen Thomson, Sarah Carlstein, Rebecca Sinclair & Gary Hulse. (2013) A Retrospective Assessment of the Use of Naltrexone Implants for the Treatment of Problematic Amphetamine Use. The American Journal on Addictions 22:1, pages 1-6.
Crossref
Jenny Häggkvist, Carl Björkholm, Pia Steensland, Sara Lindholm, Johan Franck & Björn Schilström. (2011) Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat. Addiction Biology 16:1, pages 20-29.
Crossref
Laurent Karila, Aviv Weinstein, Henri‐Jean Aubin, Amine Benyamina, Michel Reynaud & Steven L. Batki. (2010) Pharmacological approaches to methamphetamine dependence: a focused review. British Journal of Clinical Pharmacology 69:6, pages 578-592.
Crossref
Bianca Jupp & Andrew J. Lawrence. (2010) New horizons for therapeutics in drug and alcohol abuse. Pharmacology & Therapeutics 125:1, pages 138-168.
Crossref
Mark S. Todtenkopf, Krystal S. O'Neill, Kristina Kriksciukaite, Ryan Z. Turncliff, Reginald L. Dean, Irina Ostrovsky‐Day & Daniel R. Deaver. (2009) PRECLINICAL STUDY: Route of administration affects the ability of naltrexone to reduce amphetamine‐potentiated brain stimulation reward in rats. Addiction Biology 14:4, pages 408-418.
Crossref
Jenny Häggkvist, Sara Lindholm & Johan Franck. (2009) The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat. Addiction Biology 14:3, pages 260-269.
Crossref
Euphrosyne Gouzoulis-Mayfrank & Norbert Scherbaum. 2009. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 39 54 .
Frank J. Vocci & Nathan M. Appel. (2007) Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 102, pages 96-106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.